687 Proteomic profiling in blood identifies novel pretreatment and mechanistic markers related to inflammatory adverse events in relapsed/refractory large B-cell lymphoma after axicabtagene ciloleucel

Kelly Speth; Gayatri Tiwari; Sabina Adhikary; Qinghua Song; Justin Chou; Frederick Locke; Caron Jacobson; David Miklos; Olalekan Oluwole; Marie José Kersten; Max Topp; Jenny Kim; Adrian Bot

doi:10.1136/jitc-2022-SITC2022.0687

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

687 Proteomic profiling in blood identifies novel pretreatment and mechanistic markers related to inflammatory adverse events in relapsed/refractory large B-cell lymphoma after axicabtagene ciloleucel

Free

Authors

Kelly Speth Kite, a Gilead Company, Santa Monica, CA, USA PubMed articles Google scholar articles
Gayatri Tiwari Kite, a Gilead Company, Santa Monica, CA, USA PubMed articles Google scholar articles
Sabina Adhikary Kite, a Gilead Company, Santa Monica, CA, USA PubMed articles Google scholar articles
Qinghua Song Kite, a Gilead Company, Santa Monica, CA, USA PubMed articles Google scholar articles
Justin Chou Kite, a Gilead Company, Santa Monica, CA, USA PubMed articles Google scholar articles
Frederick Locke Moffitt Cancer Center, Tampa, FL, USA PubMed articles Google scholar articles
Caron Jacobson Dana-Farber Cancer Institute, Boston, MA, USA PubMed articles Google scholar articles
David Miklos Stanford University School of Medicine, Stanford, CA, USA PubMed articles Google scholar articles
Olalekan Oluwole Vanderbilt University Cancer Center, Nashville, TN, USA PubMed articles Google scholar articles
Marie José Kersten Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands PubMed articles Google scholar articles
Max Topp Universitätsklinikum Würzburg, Wurzburg, Germany PubMed articles Google scholar articles
Jenny Kim Kite, a Gilead Company, Santa Monica, CA, USA PubMed articles Google scholar articles
Adrian Bot Kite, a Gilead Company, Santa Monica, CA, USA PubMed articles Google scholar articles

Citation

Speth K, Tiwari G, Adhikary S, et al

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0687

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password